Aesthetics
A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines
Dermatologic Surgery
- Author: Green, Jeremy B. MD et al.
Dermatologic Surgery
Dermatologic Surgery
Dermatologic Surgery
Journal of the American Academy of Dermatology
Dermatologic Surgery
Plastic and Reconstructive Surgery
DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA and is currently under regulatory review.
* DaxibotulinumtoxinA for Injection was formerly known as RT002.